Ratings for Globus Medical (NYSE:GMED) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $85.0, a high estimate of $100.00, and a low estimate of $77.00. This current average has increased by 13.77% from the previous average price target of $74.71.

Analyzing Analyst Ratings: A Detailed Breakdown

An in-depth analysis of recent analyst actions...